litlas
ログインアカウント作成

John P. Leonard

1979–2025 年に発表

171
論文数
30,706
被引用数
93
h 指数
165
i10 指数

被引用数

John P. Leonard の年別被引用数1973 年: 被引用 1 件1981 年: 被引用 2 件1982 年: 被引用 3 件1983 年: 被引用 1 件1984 年: 被引用 8 件1985 年: 被引用 5 件1986 年: 被引用 3 件1987 年: 被引用 2 件1988 年: 被引用 5 件1989 年: 被引用 3 件1990 年: 被引用 2 件1991 年: 被引用 5 件1992 年: 被引用 27 件1993 年: 被引用 33 件1994 年: 被引用 28 件1995 年: 被引用 39 件1996 年: 被引用 44 件1997 年: 被引用 51 件1998 年: 被引用 84 件1999 年: 被引用 65 件2000 年: 被引用 52 件2001 年: 被引用 65 件2002 年: 被引用 69 件2003 年: 被引用 93 件2004 年: 被引用 89 件2005 年: 被引用 127 件2006 年: 被引用 99 件2007 年: 被引用 144 件2008 年: 被引用 148 件2009 年: 被引用 130 件2010 年: 被引用 183 件2011 年: 被引用 224 件2012 年: 被引用 213 件2013 年: 被引用 216 件2014 年: 被引用 207 件2015 年: 被引用 232 件2016 年: 被引用 156 件2017 年: 被引用 198 件2018 年: 被引用 215 件2019 年: 被引用 720 件2020 年: 被引用 845 件2021 年: 被引用 913 件2022 年: 被引用 928 件2023 年: 被引用 690 件2024 年: 被引用 1,209 件2025 年: 被引用 580 件2026 年: 被引用 16 件1974〜1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,947 件、この内訳の 30.8%中国: 引用元論文 986 件、この内訳の 7.7%イギリス: 引用元論文 838 件、この内訳の 6.5%ドイツ: 引用元論文 799 件、この内訳の 6.2%イタリア: 引用元論文 703 件、この内訳の 5.5%フランス: 引用元論文 587 件、この内訳の 4.6%カナダ: 引用元論文 517 件、この内訳の 4%スペイン: 引用元論文 387 件、この内訳の 3%スイス: 引用元論文 369 件、この内訳の 2.9%オーストラリア: 引用元論文 367 件、この内訳の 2.8%オランダ: 引用元論文 342 件、この内訳の 2.7%日本: 引用元論文 335 件、この内訳の 2.6%
0%30.8%その他 20.7%

機関

分野

  • Medicine57.6%
  • Biochemistry, Genetics and Molecular Biology27.9%
  • Immunology and Microbiology8.4%
  • Neuroscience3.4%
  • Engineering0.4%
  • Computer Science0.4%
  • その他1.9%

トピック

  • Lymphoma Diagnosis and Treatment10.5%
  • CAR-T cell therapy research4.9%
  • Chronic Lymphocytic Leukemia Research4.8%
  • Immune Cell Function and Interaction3%
  • Viral-associated cancers and disorders2.3%
  • CNS Lymphoma Diagnosis and Treatment2.2%
  • その他72.3%

共著者

全論文

検索で開く
  1. CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

    著者: Julian D. Gillmore, Ed Gane, Jörg Täubel, Justin Kao, Marianna Fontana, Michael L. Maitland, Jessica Seitzer, Daniel O’Connell, Kathryn Walsh, Kristy Wood, Jonathan D. Phillips, Yuanxin Xu, Adam Amaral, Adam P. Boyd, Jeffrey Cehelsky, Mark D. McKee, Andrew Schiermeier, Olivier Harari, Andrew Murphy, Christos A. Kyratsous, Brian Zambrowicz, Randy Soltys, David E. Gutstein, John P. Leonard, Laura Sepp‐Lorenzino, David Lebwohl - New England Journal of Medicine 2021 被引用: 1,633

  2. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: Elı́as Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Doǧan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesús F. San Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana H. Advani, Stephen M. Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  3. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    著者: Roland Schmitz, George W. Wright, Da Wei Huang, Calvin A. Johnson, James D. Phelan, James Q. Wang, Sandrine Roulland, Monica Kasbekar, Ryan M. Young, Arthur L. Shaffer, Daniel J. Hodson, Wenming Xiao, Xin Yu, Yandan Yang, Hong Zhao, Weihong Xu, Xuelu Liu, Bin Zhou, Wei Du, Wing C. Chan, Elaine S. Jaffe, Randy D. Gascoyne, Joseph M. Connors, Elı́as Campo, Armando López‐Guillermo, Andreas Rosenwald, German Ott, Jan Delabie, Lisa M. Rimsza, Kevin Tay Kuang Wei, Andrew D. Zelenetz, John P. Leonard, Nancy L. Bartlett, Bao Tran, Jyoti Shetty, Yongmei Zhao, Dan Soppet, Stefania Pittaluga, Wyndham H. Wilson, Louis M. Staudt - New England Journal of Medicine 2018 被引用: 2,261

  4. CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema

    著者: Hilary Longhurst, Karen Lindsay, Remy S. Petersen, Lauré M. Fijen, Padmalal Gurugama, David Maag, James S. Butler, Mrinal Y. Shah, A. Golden, Yuanxin Xu, Carri Boiselle, Joseph D Vogel, Ahmed M. Abdelhady, Michael L. Maitland, Mark D. McKee, Jessica Seitzer, Bo Han, Samantha Soukamneuth, John P. Leonard, Laura Sepp‐Lorenzino, Eliana D Clark, David Lebwohl, Danny M. Cohn - New England Journal of Medicine 2024 被引用: 166

  5. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

    著者: Wyndham H. Wilson, Owen A. O’Connor, Myron S. Czuczman, Ann S. LaCasce, John F. Gerecitano, John P. Leonard, Anil Tulpule, Kieron Dunleavy, Hao Xiong, Yi‐Lin Chiu, Yue Cui, Todd Busman, Steven W. Elmore, Saul H. Rosenberg, Andrew Krivoshik, Sari H. Enschede, Rod Humerickhouse - The Lancet Oncology 2010 被引用: 853

  6. Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures

    著者: Nikita Kotlov, Alexander Bagaev, María V. Revuelta, Jude M. Phillip, Maria Teresa Cacciapuoti, Zoya Antysheva, Viktor Svekolkin, Ekaterina Tikhonova, Natalia Miheecheva, Natalia Kuzkina, Grigorii Nos, Fabrizio Tabbò, Felix Frenkel, Paola Ghione, Maria Tsiper, Nava Almog, Nathan Fowler, Ari Melnick, John P. Leonard, Giorgio Inghirami, Leandro Cerchietti - Cancer Discovery 2021 被引用: 251

  7. AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

    著者: John P. Leonard, Marek Trněný, Koji Izutsu, Nathan Fowler, Xiaonan Hong, Jun Zhu, Huilai Zhang, Fritz Offner, Adriana Scheliga, Grzegorz S. Nowakowski, Antonio Pinto, Francesca Re, Laura Maria Fogliatto, Phillip Scheinberg, Ian W. Flinn, Cláudia Moreira, José Cabeçadas, David Liu, Stacey Kalambakas, Pierre Fustier, Chengqing Wu, John G. Gribben, for the AUGMENT Trial Investigators - Journal of Clinical Oncology 2019 被引用: 421

  8. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

    著者: Nancy L. Bartlett, Wyndham H. Wilson, Sin‐Ho Jung, Eric D. Hsi, Matthew J. Maurer, Levi Pederson, Mei‐Yin C. Polley, Brandelyn N. Pitcher, Bruce D. Cheson, Brad S. Kahl, Jonathan W. Friedberg, Louis M. Staudt, Nina D. Wagner‐Johnston, Kristie A. Blum, Jeremy S. Abramson, Nishitha Reddy, Jane N. Winter, Julie Chang, Ajay K. Gopal, Amy Chadburn, Susan Mathew, Richard I. Fisher, Kristy L. Richards, Heiko Schöder, Andrew D. Zelenetz, John P. Leonard - Journal of Clinical Oncology 2019 被引用: 423

  9. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.

    著者: John P. Leonard, Matthew L. Sherman, Gerald L. Fisher, Lynn J. Buchanan, G R Larsen, Michael B. Atkins, Jeffrey A. Sosman, Janice P. Dutcher, Nicholas J. Vogelzang, John L. Ryan - 1997 被引用: 814

  10. Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

    著者: Anas Younes, Nancy L. Bartlett, John P. Leonard, Dana A. Kennedy, Carmel M. Lynch, Eric L. Sievers, Andres Forero‐Torres - New England Journal of Medicine 2010 被引用: 1,353

  11. SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL).

    著者: Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens, Kelly Davison, Angela Punnett, David Hodgson, Susan K. Parsons, Sairah Ahmed, Carla Casulo, Nancy L. Bartlett, Joo Y. Song, Richard F. Little, Brad S. Kahl, John P. Leonard, Kara M. Kelly, Sonali M. Smith, Jonathan W. Friedberg - Journal of Clinical Oncology 2023 被引用: 117

  12. Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

    著者: Richard Piekarz, Robin Frye, Maria L. Turner, John J. Wright, Steven L. Allen, Mark Kirschbaum, Jasmine Zain, H. Miles Prince, John P. Leonard, Larisa J. Geskin, Craig B. Reeder, David Joske, William D. Figg, Erin R. Gardner, Seth M. Steinberg, Elaine S. Jaffe, Maryalice Stetler‐Stevenson, Stephen Lade, Antonio Tito Fojo, Susan E. Bates - Journal of Clinical Oncology 2009 被引用: 737

  13. Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors

    著者: Timothy A. Yap, Jane N. Winter, Lisa Giulino‐Roth, Jemma Longley, Juanita Lopez, Jean‐Marie Michot, John P. Leonard, Vincent Ribrag, Michael T. McCabe, Caretha L. Creasy, Melissa Stern, Teodora Pene Dumitrescu, Xiaowei Wang, Steve Frey, Jennifer Carver, Thierry Horner, Choon Oh, Ahmed Khaled, Arindam Dhar, Peter Johnson - Clinical Cancer Research 2019 被引用: 164

  14. Safety and efficacy of navitoclax, a BCL-2 and BCL-X L inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study

    著者: Sven de Vos, John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod Humerickhouse, John Hayslip, John C. Pesko, Wyndham H. Wilson - Leukemia & lymphoma/Leukemia and lymphoma 2020 被引用: 93

  15. Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

    著者: Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens, Kelly Davison, Angela Punnett, Susan K. Parsons, Sairah Ahmed, Carla Casulo, Nancy L. Bartlett, Joseph M. Tuscano, Matthew Mei, Brian Hess, Ryan Jacobs, Hayder Saeed, Pallawi Torka, Boyu Hu, Craig H. Moskowitz, Supreet Kaur, Gaurav Goyal, Christopher J. Forlenza, Andrew Doan, Adam J. Lamble, Pankaj Kumar, Saeeda Chowdhury, Brett T. Brinker, Namita Sharma, Avina K. Singh, Kristie A. Blum, Anamarija M. Perry, Alexandra E. Kovach, David Hodgson, Louis S. Constine, Lale Kostakoglu Shields, Anca Prica, Hildy Dillon, Richard F. Little, Margaret A. Shipp, Michael Crump, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Joo Y. Song, Kara M. Kelly, Jonathan W. Friedberg - New England Journal of Medicine 2024 被引用: 200

  16. Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients

    著者: Syed Mahmood, Peter A. Riedell, Stephanie Feldman, Gina George, Stephen Sansoterra, Thomas Althaus, Mahin Rehman, Elena Mead, Jennifer E. Liu, Richard B. Devereux, Jonathan W. Weinsaft, Jiwon Kim, Lauren Balkan, Tarek Barbar, Katherine Lee Chuy, Bhisham Harchandani, Miguel‐Angel Perales, Mark B. Geyer, Jae H. Park, M Lia Palomba, Roni Shouval, Ana Alarcón Tomás, Gunjan L. Shah, Eric H. Yang, Daria Gaut, Michael Rothberg, Evelyn M. Horn, John P. Leonard, Koen van Besien, Matthew J. Frigault, Zhengming Chen, Bhoomi Mehrotra, Tomas G. Neilan, Richard M. Steingart - European Heart Journal 2023 被引用: 48

  17. Postibrutinib outcomes in patients with mantle cell lymphoma

    著者: Peter Martin, Kami J. Maddocks, John P. Leonard, Jia Ruan, André Goy, Nina D. Wagner‐Johnston, Simon Rule, Ranjana H. Advani, David Iberri, Tycel Phillips, Stephen E. Spurgeon, Eliana Kozin, Katherine Noto, Zhengming Chen, Wojciech Jurczak, Rebecca Auer, Ewa Chmielowska, Stephan Stilgenbauer, Johannes Bloehdorn, Craig A. Portell, Michael E. Williams, Martin Dreyling, Paul M. Barr, Selina Chen‐Kiang, Maurizio DiLiberto, Richard R. Furman, Kristie A. Blum - Blood 2016 被引用: 283

  18. Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

    著者: Owen A. O’Connor, Muhıt Özcan, Eric D. Jacobsen, Josep M. Roncero, Judith Trotman, Judit Demeter, Tamás Masszi, Juliana Pereira, Radhakrishnan Ramchandren, Anne Beaven, Dolores Caballero, Steven M. Horwitz, Anne Lennard, Mehmet Turgut, Nelson Hamerschlak, Francesco d’Amore, Francine M. Foss, Won-Seog Kim, John P. Leonard, Pier Luigi Zinzani, Carlos Chiattone, Eric D. Hsi, Lorenz Trümper, Hua Liu, Emily Sheldon‐Waniga, Claudio Dansky Ullmann, Karthik Venkatakrishnan, E. Jane Leonard, Andrei R. Shustov, on behalf of the Lumiere Study Investigators - Journal of Clinical Oncology 2019 被引用: 150

  19. Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma

    著者: David Chiron, Maurizio Di Liberto, Peter Martin, Xiangao Huang, Jeff P. Sharman, Pedro Blecua, Susan Mathew, Priyanka Vijay, Ken Eng, Siraj M. Ali, Amy J. Johnson, Betty Chang, Scott Ely, Olivier Elemento, Christopher E. Mason, John P. Leonard, Selina Chen‐Kiang - Cancer Discovery 2014 被引用: 272

  20. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

    著者: Anas Younes, Patrick Hilden, Bertrand Coiffier, Anton Hagenbeek, Gilles Salles, Wyndham H. Wilson, John F. Seymour, Kara M. Kelly, John G. Gribben, M. Pfreunschuh, Franck Morschhauser, Heiko Schöder, Andrew D. Zelenetz, Jürgen Rademaker, Ranjana H. Advani, Nancy Valente, Catherine Fortpied, Thomas E. Witzig, Laurie H. Sehn, Andreas Engert, Richard I. Fisher, Pier Luigi Zinzani, Massimo Federico, Martin Hutchings, Catherine M. Bollard, Marek Trněný, Yusri Elsayed, Kensei Tobinai, Jeremy S. Abramson, Nathan Fowler, André Goy, Mitchell R. Smith, Stephen M. Ansell, John Kuruvilla, Martin Dreyling, Catherine Thiéblemont, Richard F. Little, Igor Aurer, Marinus H. J. van Oers, Kenichi Takeshita, Ajay K. Gopal, Simon Rule, Sven de Vos, Ioana Kloos, Mark Kaminski, Michel Meignan, Lawrence H. Schwartz, John P. Leonard, Stephen J. Schuster, Venkatraman Seshan - Annals of Oncology 2017 被引用: 377

  21. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

    著者: Heiko Schöder, Mei‐Yin C. Polley, Michael V. Knopp, Nathan C. Hall, Lale Kostakoglu, Jun Zhang, Howard R. Higley, Gary J. Kelloff, Heshan Liu, Andrew D. Zelenetz, Bruce D. Cheson, Nina D. Wagner‐Johnston, Brad S. Kahl, Jonathan W. Friedberg, Eric D. Hsi, John P. Leonard, Lawrence H. Schwartz, Wyndham H. Wilson, Nancy L. Bartlett - Blood 2020 被引用: 94

  22. Positron Emission Tomography–Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001

    著者: Daniel O. Persky, Hongli Li, Deborah M. Stephens, Steven I. Park, Nancy L. Bartlett, Lode J. Swinnen, Paul M. Barr, Jerome D. Winegarden, Louis S. Constine, Thomas J. FitzGerald, John P. Leonard, Brad S. Kahl, Michael LeBlanc, Joo Y. Song, Richard I. Fisher, Lisa M. Rimsza, Sonali M. Smith, Thomas P. Miller, Jonathan W. Friedberg - Journal of Clinical Oncology 2020 被引用: 128

  23. Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma

    著者: Thomas Clozel, ShaoNing Yang, Rebecca Elstrom, Wayne Tam, Peter Martin, Matthías Kormáksson, Samprit Banerjee, Aparna Vasanthakumar, Biljana Čuljković, David W. Scott, Sarah Wyman, Micheal Leser, Rita Shaknovich, Amy Chadburn, Fabrizio Tabbò, Lucy A. Godley, Randy D. Gascoyne, Katherine L. B. Borden, Giorgio Inghirami, John P. Leonard, Ari Melnick, Leandro Cerchietti - Cancer Discovery 2013 被引用: 214

  24. A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology

    著者: Matthew J. Birket, Sophie Raibaud, Miriam Lettieri, Antony Adamson, Valérie Letang, Pauline Cervello, Nicolas Redon, Gwénaëlle Ret, Sandra Viale, Bing Wang, Bruno Biton, Jean‐Claude Guillemot, Vincent Mikol, John P. Leonard, Neil A. Hanley, Cécile Orsini, Jean‐Michel Itier - Stem Cell Reports 2019 被引用: 78